Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04754217 · ClinicalTrials.gov registry record

Valved Graft PMCF Study

A clinical trial of Aortic Valve Disease and Aortic Dissection, sponsored by Abbott Medical Devices.

Recruiting
Registry status
260
Enrollment target
20
Study locations

NCT04754217 is a study of Aortic Valve Disease and Aortic Dissection that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 260 participants, below the 18,600-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04754217, a study of Aortic Valve Disease and Aortic Dissection, is actively recruiting participants, sponsored by Abbott Medical Devices.

RECRUITING
Registry status
260 participants
Enrollment target
20
Study locations

Study Summary

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

Conditions Studied

Aortic Valve Disease Aortic Dissection Ascending Aorta Abnormality

Interventions

  • DEVICE VAVGJ
  • DEVICE CAVGJ

Study Locations (20)

Other

  • Klinik Floridsdorf - Vienna
  • Rigshospitalet - Copenhagen
  • CHU de Besancon - Jean Minjoz - Besançon
  • CHRU Lille - Lille
  • Groupe Hospitalier Bichat - Claude Bernard - Paris
  • Herz-und Diabetes Zentrum NRW - Bad Oeynhausen
  • Deutsches Herzzentrum Berlin - Berlin
  • Klinikum Links der Weser - Bremen
  • Medizinische Hochschule Hannover - Hanover
  • Onassis Cardiac Surgery Center - Athens
  • Policlinico S.Orsola-Malpighi - Bologna
  • Ospedale San Raffaele - Milan
  • Policlinico San Donato - San Donato Milanese
  • Wojewodzki Szpital Zespolony w Kielcach - Kielce
  • Krakowski Szpital Specjalistyczny im. Jana Pawla II - Krakow

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

Alabama

  • University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham

Michigan

  • University of Michigan - Ann Arbor

North Carolina

  • Mission Health & Hospitals - Asheville

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2021-07-13
Est. Completion 2029-09

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04754217

The ClinicalTrials.gov registry entry for NCT04754217 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,600-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Aortic Valve Disease appearing as the primary indexed condition, and to 2 interventions - of which VAVGJ is the first listed.

NCT04754217 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Other, Pennsylvania, Alabama.

Frequently Asked Questions

What is clinical trial NCT04754217 about?

NCT04754217 is a clinical study titled "Valved Graft PMCF Study". Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

What is the current status of trial NCT04754217?

This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2021-07-13. Estimated completion is 2029-09.

What conditions does trial NCT04754217 study?

This clinical trial studies the following conditions: Aortic Valve Disease, Aortic Dissection, Ascending Aorta Abnormality.

What interventions are being tested in trial NCT04754217?

The interventions under investigation include: VAVGJ (DEVICE), CAVGJ (DEVICE).

Who is sponsoring clinical trial NCT04754217?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04754217 being conducted?

This trial has 20 study locations across Alabama, Michigan, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aortic Valve Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aortic Valve Disease

All registered trials for this condition

Aortic Dissection

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.